Research study using removed tissue from soft-tissue sarcoma
Part of Cancer clinical trials.
This study looks at tissue (samples taken during diagnosis or treatment) to learn new biological and molecular clues about soft-tissue sarcoma. Participating mainly helps researchers collect usable tissue that would otherwise be discarded.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a known or suspected soft-tissue sarcoma and are having tissue removed for diagnosis or treatment
- The study needs enough tissue for regular pathology tests and for extra research testing
- If possible, your team can collect small additional research samples (like core or biopsy pieces) from what’s removed
- You may have had prior treatments (hormone therapy, chemo, radiation, immunotherapy, or surgery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
This study compares two surgical approaches for treating sarcoma in the arm or leg. It tests whether removing the needle biopsy tract (the path of the biopsy needle) along with the tumor lowers the chance of the cancer coming back.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This study uses a simple blood test (liquid biopsy) to look for tiny pieces of tumor DNA in people with sarcoma. It may help doctors learn more about the disease and guide treatment decisions, whether you are just diagnosed, being treated, or have finished treatment recently.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.